Internal Medicine, Endocrinology, Diabetes, & Metabolism · Conway, AR
NPI
1679886618
Since 2010
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
525 Western Ave Ste 305b
Conway, AR, 72034
Phone (501) 205-4990
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
533 services
Medicare patients, 2024
239
Average age 70
Drug cost, 2024
$713K
2,035 prescriptions
Company payments, 2025
$487
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria Javaid was code 99214 (office e&m - established), 247 times for 165 patients. In total Maria Javaid billed 533 services in 7 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 247 | 165 | $64.87 | $16K |
| 99213 Office E&M - Established | Facility | 127 | 97 | $39.18 | $4,976 |
| 95251 Test - Miscellaneous | Facility | 114 | 70 | $23.61 | $2,691 |
| 99204 Office E&M - New | Facility | 37 | 37 | $85.80 | $3,175 |
By year: 2022 $20K for 255 services; 2023 $30K for 490 services; 2024 $27K for 533 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria Javaid prescribed most often to Medicare patients was Levothyroxine Sodium, with 223 prescriptions and refills. In total Maria Javaid wrote 2,035 Medicare prescriptions that cost $713K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 223 | 440 | 71 | $60K |
| Ozempic Semaglutide | 158 | 191 | 46 | $161K |
| Synthroid Levothyroxine Sodium | 153 | 267 | 50 | $13K |
| Mounjaro Tirzepatide | 94 | 108 | 20 | $113K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 77 | 149 | 33 | $9,943 |
| Methimazole Generic | 71 | 119 | 21 | $562 |
| Tresiba Flextouch U-100 Insulin Degludec | 65 | 114 | 18 | $46K |
| Metformin Hcl Generic | 58 | 128 | 25 | $312 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 56 | 72 | 15 | $47K |
| Novolog Flexpen Insulin Aspart | 55 | 75 | 18 | $12K |
| Metformin Hcl Er Metformin Hcl | 53 | 94 | 19 | $305 |
| Hydrocortisone Generic | 43 | 68 | 14 | $1,364 |
| Humalog Kwikpen U-100 Insulin Lispro | 39 | 47 | 14 | $7,667 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 38 | 51 | Under 11 | $8,580 |
| Jardiance Empagliflozin | 37 | 45 | 12 | $26K |
Brand drugs: 1,273 claims; generic drugs: 638 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria Javaid $487 ($487 in general payments such as food, travel and fees) from 12 companies. The largest payer was Medtronic, Inc. with $237.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.